ABOUT IAPAC | CONTACT | IAPAC HOME
 
 

CONFERENCE YEAR

2017

2016

2014

2013

2012

2011

 

International Conference on Viral Hepatitis 2014

The 2014 International Conference on Viral Hepatitis was jointly sponsored by the International Association of Providers of AIDS Care (IAPAC) and the Icahn School of Medicine at Mount Sinai, in partnership with the International Association for the Study of the Liver (IASL). The conference was Co-Chaired by Dr. Douglas T. Dieterich (Icahn School of Medicine at Mount Sinai, New York, NY, USA), Dr. Mario U. Mondelli (University of Pavia, Pavia, Italy), and Dr. Mark R. Nelson (Chelsea & Westminster Hospital, London, England). Following are conference presentations. The conference organizers request that any use of these presentations should include citations to both their presenting authors and relevant conference information (e.g., 2014 International Conference on Viral Hepatitis, March 17-18, 2014, New York).

The International Association of Providers of AIDS Care (IAPAC) is pleased to announce that select ICVH 2014 plenary presentations, panel discussions, and oral abstract sessions are available as archived webcast sessions. Click here to register for free online access to the archived webcast sessions.

 

MONDAY, March 17, 2014

PLENARY 1 - Global Snapshot of Viral Hepatitis Morbidity and Mortality
Kiren Mitruka, MD, MPH, US Centers for Disease Control and Prevention, Atlanta, GA, USA

KEYNOTE ADDRESS - The HCV Epidemic and Its Cure(s): Placing the State of the Science into Much-Needed Context and Perspective
Mario U. Mondelli, MD, PhD, University of Pavia, Pavia, Italy

PLENARY 2 - HBV State-of-the-Science
Tram T. Tran, MD, Cedars-Sinai Medical Center, Los Angeles, CA, USA

PLENARY 3 - HCV State-of-the-Science
Massimo Puoti, MD, AO Ospedale Niguarda Cà Granda, Milan, Italy

PANEL DISCUSSION 1 - Patient Perspectives on What Providers Need to Know about Stigma and other Barriers to Hepatitis Care
Moderator: Helen-Maria Lekas, PhD, Columbia University, New York, NY, USA
Panelist 1: Jules Levin, National AIDS Treatment Advocacy Project, New York, NY, USA
Panelist 2: Gloria Searson, ACSW, Coalition on Positive Health Empowerment, New York, NY, USA
Panelist 3: Alyson Harty, RN, Mount Sinai Medical Center, New York, NY, USA
Panelist 4: William Thompson, New York, NY

PLENARY 4 - Recognizing Advanced Liver Disease for the New HCV Treater
Kosh Agarwal, MD, King’s College Hospital, London, England

PLENARY 5 - HIV Infection with HCV Future Directions
Ranjababu Kulasegaram, MD, FRCP, Guy’s and St. Thomas’ NHS Foundation Trust, London, England

PLENARY 6 - Hepatocellular Carcinoma — State of the Science Review
Sasan Roayaie, MD, Hofstra North Shore-LIJ School of Medicine, Manhasset, NY, USA

PLENARY 7 - Liver Transplant in HIV — Reopening the Debate
K. Rajender Reddy, MD, University of Pennsylvania, Philadelphia, PA, USA

 

TUESDAY, March 18, 2014

PANEL DISCUSSION 2 - Strengthening the HCV Continuum of Care
Moderator: Mario U. Mondelli, MD, PhD
Presenter: Fabienne Laraque, MD, MPH, The New York City Department of Health and Mental Hygiene, New York, NY, USA Presentation
Discussants: Kosh Agarwal, MD, King’s College Hospital, London, England
Jeffrey Kwong, DNP, MPH, ANP-BC, Columbia University, New York, NY, USA
Federico G. Villamil, MD, British Hospital of Buenos Aires, Buenos Aires, Argentina

PLENARY 8 - Key Issues in Drug Interactions in the Direct-Acting Antiviral Era
David J. Back, PhD, University of Liverpool, Liverpool, England

PLENARY 9 - Adherence in the Age of HCV Antiviral Therapy
Jeffrey Weiss, PhD, Icahn School of Medicine at Mount Sinai, New York, NY, USA

PANEL DISCUSSION 3 - Managing Viral Hepatitis in Primary Health Care Settings and Exploring the Role of Non-Physician Clinicians
Moderator: Jeffrey Kwong, DNP, MPH, ANP-BC, Columbia University, New York, NY, USA
Panelist 1: Sherilyn Brinkley, CRNP, Johns Hopkins University, Baltimore, MD, USA Presentation
Panelist 2: Donald Gardenier, DNP, FNP-BC, Icahn School of Medicine at Mount Sinai, New York, NY, USA Presentation
Panelist 3: Michelle T. Martin, PharmD, BCPS, BCACP, University of Illinois, Chicago, IL, USA Presentation
Panelist 4: Jeffrey Weiss, PhD, Icahn School of Medicine at Mount Sinai, New York, NY, USA Presentation

CASE STUDY SESSION - Complicated Cases
Acute and Chronic HBV/HCV
Alex Salam, MBChB, MSc, MRCP, Chelsea and Westminster Hospital, London, England
 
Antiviral Therapy Before and After Liver Transplantation
Federico G. Villamil, MD, British Hospital of Buenos Aires, Buenos Aires, Argentina

CASE STUDY SESSION - Vulnerable Populations
Children and Adolescents
Ivana Carey, MD, PhD, King’s College London, London, England

PANEL DISCUSSION 4 - Reinfection: A Limiting Factor for HCV Treatment as Prevention?
Moderator: Mark R. Nelson, MD, Chelsea & Westminster Hospital, London, England
Presenter: Thomas C.S. Martin, MS, MA, BMBCh, MRCP, Chelsea & Westminster Hospital, London, England Presentation
Discussant: Natasha Martin, PhD, University of Bristol, Bristol, England Presentation

PLENARY 10 - Pregnancy and Hepatitis - An Underestimated Clinical Management Issue
Tram T. Tran, MD, Cedars-Sinai Medical Center, Los Angeles, CA, USA

PLENARY 11 - The Future of HCV in Men who have Sex with Men
Emma Page, MBBS, MRCP, Chelsea & Westminster Hospital, London, England

RAPPORTEUR SESSION AND 2 TOP-RATED ABSTRACTS - Bridging Barriers to Improve Viral Hepatitis Patient Outcomes in Diverse Communities and Populations
Douglas T. Dieterich, MD, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Mark R. Nelson, MD, Chelsea & Westminster Hospital, London, England
Mario U. Mondelli, MD, PhD, University of Pavia, Pavia, Italy

 

ORAL ABSTRACT PRESENTATIONS

48 - Hepatitis C Screening, Retesting, and Treatment Discussion among HIV-Positive Persons in Care, 2011
Bruce Agins presenting

49 - Does the Addition of HCV Testing to a Rapid HIV Testing Program Impact HIV Test Acceptance? A Randomized Controlled Trial
Sara Rahman presenting

50 - Elevated Mortality Risk in HIV/HCV-Coinfected Patients: Risk Assessment Using the VACS Index
Oluwatoyin Adeyemi presenting

51 - New All Oral Therapy for Chronic Hepatitis C Virus (HCV): A Cost-Benefit Analysis
Jennifer Orsi presenting

54 - Patient Management Programs Lead to Improved Adherence for Patients with Hepatitis C using Drug Dual Therapy in Both Retail and Central Pharmacies
Jennifer Orsi presenting on behalf of Francis Staskon

55 - Perceptions of Genetic Testing and Genomic Medicine as Part of Hepatitis C Care among Urban Drug Users
David Perlman presenting

57 - The CORE HCV Cascade: Evaluating Gaps in Hepatitis C Virus (HCV) Evaluation in HIV/HCV Coinfected Patients
Oluwatoyin Adeyemi presenting

59 - High Yield and Feasibility of HCV Birth Cohort Screening in Two Urban, Academic Emergency Departments
James Galbraith presenting

60 - The Role of Social Work in an Interdisciplinary, Hepatitis C Treatment Team
Catherine Amory presenting

61 - HCV Care Cascade Outcomes in a Non-Clinical, Neighborhood-Based Testing and Linkage Program
Stacey Trooskin presenting

62 - Primary Care-Based Hepatitis C Treatment in the First Generation Triple Therapy Era
Keith M. Sigel presenting

63 - Economics of Rapid Hepatitis C Screening in Correctional Facilities
John Wong presenting

65 - Use of In-Care Viral Load to Assess Care of Hepatitis C in the District of Columbia
Monique Millington presenting

67 - Hepatitis C Capacity Strengthening Program with Aboriginal Medical Services In Regional Australia
Beth Wilson presenting

 

2014 Conference Program and Abstracts
Click below to download the complete 2014 Program in PDF format.

ICVH 2014 Program

Requires free Acrobat Reader Plugin Software
Get Adobe Reader


 
line
©2014 International Association of Providers of AIDS Care. All Rights Reserved.